The agency also is considering whether additional words such as "This is temporary and not serious" would be beneficial. FDA said it has received a number of complaints about dilated pupils and hoped the warning would reduce the number of adverse incidents. FDA is also proposing that product labeling requirements for these products be amended to read, "If you have narrow-angle glaucoma, do not use this product except under the advice and supervision of a doctor." Currently, the warning applies to those having glaucoma of any type.
Eye drug warnings
Labels of popular OTC eye allergy relief drugs such as Pfizer's Visine, Ross Labs' Murine Tears Plus and Clear Eyes ACR, Bausch & Lomb's Sensitive Eyes, and other vasoconstrictor drugs containing ephedrine, naphazoline, phenylephrine, and tetrahydrozaline should include the warning "Pupils may become dilated (enlarged)," according to an FDA proposal.
Mar 31, 1998
Recommended
Machinery Basics
Conveyor setup secrets from top CPG manufacturers
7 proven steps to eliminate downtime and boost packaging line efficiency. Free expert playbook reveals maintenance, sequencing, and handling strategies.
Read More
Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? Packaging World editors explore the survey responses from 118 brand owners, CPG, and FMCG Packaging World readers for its new Annual Outlook Report.
Download
Downloads
